MyFinsight
Home
Blog
About
Contact
Download
Download image
Sale of common stock,
net of offering...
$3,579K
Net cash provided by
financing activities
$3,579K
Net (decrease)
increase in cash, cash...
-$683K
Canceled cashflow
$3,579K
Depreciation and
amortization
$4,123K
Accounts receivable
-$1,003K
Stock-based compensation
expense
$643K
Accounts payable
$350K
Amortization of operating
lease right-of-use...
$344K
Amortization of deferred
financing costs and debt...
$157K
Provision for credit
losses
$129K
Loss on disposal of
property and equipment
-$92K
Net cash (used in)
provided by operating...
-$2,794K
Canceled cashflow
$6,841K
Net cash used in
investing activities
-$1,468K
Net loss
-$6,261K
Accrued expenses and
other liabilities
-$1,248K
Settlement gains
$1,135K
Operating lease
liabilities
-$328K
Inventories
$288K
Prepaid expenses and
other assets
$252K
Deferred revenues
-$123K
Purchase of property and
equipment
$1,468K
Back
Back
Cash Flow
source: myfinsight.com
STRATA Skin Sciences, Inc. (SSKN)
STRATA Skin Sciences, Inc. (SSKN)